Modulation of Salmonella gene expression by subinhibitory concentrations of quinolones

Journal of Antibiotics

Volumn 64, Issue 1, 2011, Pages 73-78

  Yim, Grace ^a   McClure, Joann ^b   Surette, Michael G ^b,c   Davies, Julian E ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

bacterial gyrase; fluoroquinolone; Salmonella; small molecule; SOS response; subinhibitory; transcription

Indexed keywords

CIPROFLOXACIN; ENOXACIN; FLEROXACIN; GATIFLOXACIN; LEVOFLOXACIN; LEXA PROTEIN; MOXIFLOXACIN; NORFLOXACIN; PEFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL METABOLISM; BACTERIAL VIRULENCE; CONTROLLED STUDY; DNA DAMAGE; DRUG EFFECT; DRUG MECHANISM; DRUG RESPONSE; GENE CONTROL; GENE EXPRESSION; GROWTH INHIBITION; MODULATION; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; STRESS; UPREGULATION;

ANTI-INFECTIVE AGENTS; FLUOROQUINOLONES; GENE EXPRESSION REGULATION, BACTERIAL; MICROBIAL SENSITIVITY TESTS; MUTAGENICITY TESTS; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM; SOS RESPONSE (GENETICS);

BACTERIA (MICROORGANISMS); SALMONELLA; SALMONELLA ENTERICA;

EID: 79251606814     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.1038/ja.2010.137     Document Type: Article

References (43)

1. Hooper, D. C. & Rubinstein, E. Quinolone Antimicrobial Agents, 3rd ed. (ASM Press, Washington, DC, 2003).
2. Sutton, M. D., Smith, B. T., Godoy, V. G. & Walker, G. C. The SOS response: Recent insights into umuDC-dependent mutagenesis and DNA damage tolerance. Annu. Rev. Genet. 34, 479-497 (2000).
3. Walker, G. C. Mutagenesis and inducible responses to deoxyribonucleic acid damage in Escherichia coli. Microbiol. Rev. 48, 60-93 (1984).
4. Ysern, P. et al. Induction of SOS genes in Escherichia coli and mutagenesis in Salmonella typhimurium by fluoroquinolones. Mutagenesis. 5, 63-66 (1990).
5. Power, E. G. & Phillips, I. Correlation between umuC induction and Salmonella mutagenicity assay for quinolone antimicrobial agents. FEMS Microbiol. Lett. 112, 251-254 (1993).
6. Goh,E.B. et al. Transcriptional modulation of bacterial gene expression by subinhibitory concentrations of antibiotics. Proc. Natl Acad. Sci. USA 99, 17025-17030 (2002).
7. Maron, D. M. & Ames, B. N. Revised methods for the Salmonella mutagenicity test. Mutat. Res. 113, 173-215 (1983).
8. Kim,S.R. et al. Multiple pathways for SOS-induced mutagenesis in Escherichia coli: An overexpression of dinB/dinP results in strongly enhancing mutagenesis in the absence of any exogenous treatment to damage DNA. Proc. Natl Acad. Sci. USA 94, 13792-13797 (1997).
9. Baquero, M. R., Bouzon, M., Varea, J. & Moreno, F. sbmC, a stationary-phase induced SOS Escherichia coli gene, whose product protects cells from the DNA replication inhibitor microcin B17. Mol. Microbiol. 18, 301-311 (1995).
10. Barth, M., Marschall, C., Muffler, A., Fischer, D. & Hengge-Aronis, R. Role for the histone-like protein H-NS in growth phase-dependent and osmotic regulation of sigma S and many sigma S-dependent genes in Escherichia coli. J. Bacteriol. 177, 3455-3464 (1995).
11. Hommais, F. et al. Large-scale monitoring of pleiotropic regulation of gene expression by the prokaryotic nucleoid-associated protein, H-NS. Mol. Microbiol. 40, 20-36 (2001).
12. Oh, T. J., Jung, I. L. & Kim, I. G. The Escherichia coli SOS gene sbmC is regulated by HNS and RpoS during the SOS induction and stationary growth phase. Biochem. Biophys. Res. Commun. 288, 1052-1058 (2001).
13. Mamber, S. W., Kolek, B., Brookshire, K. W., Bonner, D. P. & Fung-Tomc, J. Activity of quinolones in the Ames Salmonella TA102 mutagenicity test and other bacterial genotoxicity assays. Antimicrob. Agents Chemother. 37, 213-217 (1993).
14. Tsui, W. H. et al. Dual effects of MLS antibiotics: Transcriptional modulation and interactions on the ribosome. Chem. Biol. 11, 1307-1316 (2004).
15. Yim, G., de la Cruz, F., Spiegelman, G. B. & Davies, J. Transcription modulation of Salmonella enterica serovar Typhimurium promoters by sub-MIC levels of rifampin. J. Bacteriol. 188, 7988-7991 (2006).
16. Mesak, L. R., Miao, V. & Davies, J. Effects of subinhibitory concentrations of antibiotics on SOS and DNA repair gene expression in Staphylococcus aureus. Antimicrob. Agents Chemother. 52, 3394-3397 (2008).
17. Hutter, B. et al. Prediction of mechanisms of action of antibacterial compounds by gene expression profiling. Antimicrob. Agents Chemother. 48, 2838-2844 (2004).
18. Freiberg, C. & Brotz-Oesterhelt, H. Functional genomics in antibacterial drug discovery. Drug Discov. Today 10, 927-935 (2005).
19. Mesak, L. R., Qi, S., Villanueva, I., Miao, V. & Davies, J. Staphylococcus aureus promoter-lux reporters for drug discovery. J. Antibiot. (Tokyo). 63, 492-498 (2010).
20. Yim, G., Huimi Wang, H. & Davies, J. The truth about antibiotics. Int. J. Med. Microbiol. 296, 163-170 (2006).
21. Gormley, N. A., Orphanides, G., Meyer, A., Cullis, P. M. & Maxwell, A. The interaction of coumarin antibiotics with fragments of DNA gyrase B protein. Biochemistry. 35, 5083-5092 (1996).
22. Gmuender, H. et al. Gene expression changes triggered by exposure of Haemophilus influenzae to novobiocin or ciprofloxacin: Combined transcription and translation analysis. Genome Res. 11, 28-42 (2001).
23. Tomasz, M. Mitomycin C: Small, fast and deadly (but very selective). Chem. Biol. 2, 575-579 (1995).
24. Diggle, S. P., Cornelis, P., Williams, P. & Camara, M. 4-quinolone signalling in Pseudomonas aeruginosa: Old molecules, new perspectives. Int. J. Med. Microbiol. 296, 83-91 (2006).
25. Heeb, S. et al. Quinolones: From antibiotics to autoinducers. FEMS Microbiol. Rev. (e-pub ahead of print; doi:10.1111/j.1574-6976.2010.00247.x) (2010).
26. Strahilevitz, J., Jacoby, G. A., Hooper, D. C. & Robicsek, A. Plasmid-mediated quinolone resistance: A multifaceted threat. Clin. Microbiol. Rev. 22, 664-689 (2009).
27. Sonstein, S. A. & Burnham, J. C. Effect of low concentrations of quinolone antibiotics on bacterial virulence mechanisms. Diagn. Microbiol. Infect. Dis. 16, 277-289 (1993).
28. Vranes, J., Zagar, Z. & Kurbel, S. Influence of subinhibitory concentrations of ceftazidime, ciprofloxacin and azithromycin on the morphology and adherence of Pfimbriated Escherichia coli. J. Chemother. 8, 254-260 (1996). (Pubitemid 26271099)
29. Majtan, J., Majtanova, L., Xu, M. & Majtan, V. In vitro effect of subinhibitory concentrations of antibiotics on biofilm formation by clinical strains of Salmonella enterica serovar Typhimurium isolated in Slovakia. J. Appl. Microbiol. 104, 1294-1301 (2008).
30. Zhang, X. et al. Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice. J. Infect. Dis. 181, 664-670 (2000).
31. Yoh, M., Frimpong, E. K., Voravuthikunchai, S. P. & Honda, T. Effect of subinhibitory concentrations of antimicrobial agents (quinolones and macrolide) on the production of verotoxin by enterohemorrhagic Escherichia coli O157:H7. Can. J. Microbiol. 45, 732-739 (1999).
32. Grif, K., Dierich, M. P., Karch, H. & Allerberger, F. Strain-specific differences in the amount of Shiga toxin released from enterohemorrhagic Escherichia coli O157 following exposure to subinhibitory concentrations of antimicrobial agents. Eur. J. Clin. Microbiol. Infect. Dis. 17, 761-766 (1998).
33. Figueroa-Bossi, N., Uzzau, S., Maloriol, D. & Bossi, L. Variable assortment of prophages provides a transferable repertoire of pathogenic determinants in Salmonella. Mol. Microbiol. 39, 260-271 (2001).
34. Ho, T. D. et al. Identification of GtgE, a novel virulence factor encoded on the Gifsy-2 bacteriophage of Salmonella enterica serovar Typhimurium. J. Bacteriol. 184, 5234-5239 (2002).
35. Majtan, V. & Majtanova, L. Postantibiotic effects and postantibiotic sub-MIC effects of ciprofloxacin, pefloxacin and amikacin on the biological properties of Salmonella strains. Folia. Microbiol. (Praha). 42, 327-332 (1997).
36. Waldor, M. K. & Friedman, D. I. Phage regulatory circuits and virulence gene expression. Curr. Opin. Microbiol. 8, 459-465 (2005).
37. Comeau, A. M., Tetart, F., Trojet, S. N., Prere, M. F. & Krisch, H. M. Phage-antibiotic synergy (PAS): Beta-lactam and quinolone antibiotics stimulate virulent phage growth. PLoS One. 2, e799 (2007).
38. Davies, J., Spiegelman, G. B. & Yim, G. The world of subinhibitory antibiotic concentrations. Curr. Opin. Microbiol. 9, 445-453 (2006).
39. Couce, A. & Blazquez, J. Side effects of antibiotics on genetic variability. FEMS Microbiol. Rev. 33, 531-538 (2009).
40. Guerin, E. et al. The SOS response controls integron recombination. Science 324, 1034 (2009).
41. Lee, H. H., Molla, M. N., Cantor, C. R. & Collins, J. J. Bacterial charity work leads to population-wide resistance. Nature 467, 82-85 (2010).
42. Dethlefsen, L., Huse, S., Sogin, M. L. & Relman, D. A. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol. 6, e280 (2008).
43. Dethlefsen, L. & Relman, D. A. Microbes and Health Sackler Colloquium: Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc. Natl Acad. Sci. USA (e-pub ahead of print; doi:10.1073/ pnas.1000087107) (2010).